CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GetRadi project focuses on advancing gene therapy for rare diseases caused by single inherited mutations. It aims to enhance gene editing techniques, improve safety, and train future leaders in the field through collaboration between academia and the pharmaceutical industry.
More than 300 million people worldwide are suffering from more than 6000 rare diseases.
Nearly all of these rare diseases are caused by a single inherited mutation and cannot be treated effectively.
Repair of the defective gene by gene editing is the only possible curative therapy.
However, only for very few rare diseases such gene editing therapy has reached the clinic.
The “Gene therapy of Rare Diseases” (GetRadi) consortium aims now to contribute strongly to the establishment of more gene the…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Sodertaelje
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Germany, Freiburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
